Medicare Part D drug Data year 2024 Generic name Source: CMS Part D Prescribers

Fulvestrant

Open in the dashboard

Part D claims

5,075

Prescriptions dispensed, refills included

Drug cost

$3,507,399

Paid at the pharmacy, in all

Prescribers

215

With 11 or more claims of it

In 2024, Medicare Part D recorded 5,075 claims for Fulvestrant from 215 prescribers, at a total drug cost of $3.5 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 33 states and territories
Part D claims for Fulvestrant by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 50 1,087 $734,203
NY 41 1,014 $1,060,366
AR 12 508 $321,100
FL 19 339 $156,935
NJ 14 285 $219,995
AZ 6 200 $81,809
AL 4 190 $160,096
PA 10 186 $144,143
GA 9 179 $107,770
TX 8 171 $82,510
TN 2 82 $66,693
LA 1 75 $53,137
NV 4 68 $20,645
OH 3 67 $38,466
MS 1 66 $17,836
The other 18 states and territories
State Prescribers Claims Drug cost
NC 3 65 $35,297
WA 3 64 $15,586
PR 5 63 $29,787
VI 2 50 $6,403
OK 1 42 $15,288
HI 1 40 $27,507
IA 2 36 $13,159
IN 2 33 $20,235
DC 2 33 $6,459
SC 2 26 $14,799
KY 1 21 $4,455
MD 1 16 $17,491
MO 1 13 $14,176
WV 1 12 $1,135
RI 1 11 $6,934
MI 1 11 $5,549
MN 1 11 $2,575
IL 1 11 $4,860

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 11 of 11
Part D claims for Fulvestrant by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Hematology-Oncology 143 3,579 $2,444,283
Medical Oncology 35 915 $652,093
Internal Medicine 14 202 $149,692
Hematology 7 171 $144,877
Nurse Practitioner 7 88 $57,429
Physician Assistant 4 50 $38,922
Interventional Pain Management 1 19 $10,153
General Surgery 1 15 $4,388
General Practice 1 13 $1,546
Family Practice 1 12 $1,443
Geriatric Medicine 1 11 $2,575

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Boris Bagdasarian Hematology-Oncology CA 125 $109,660 None on record
Diane Wilder Medical Oncology AR 102 $63,672 None on record
Noshir Dacosta Medical Oncology NY 97 $120,873 None on record
Amol Rakkar Hematology-Oncology AZ 88 $33,211 None on record
Balagopalan Nair Hematology-Oncology AR 81 $38,016 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for fulvestrant

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record